On June 5, 2019, the U.S. Food and Drug Administration announced an extension of expiration dates by four months of all lots of EpiPen 0.3 mg Auto-Injectors and its authorized generic version on the market in the U.S.
This is based on a careful review of product stability data provided by Meridian. Our hope is that the expiration extension will help alleviate the EpiPen 0.3 mg strength shortage situation as Pfizer continues its efforts to increase production.
Please review the attached table to confirm the new expiration date for your school’s supply of EpiPen or epinephrine injection 0.3 mg auto-injectors.
Visit the FDA’s website https://www.fda.gov/media/127690/download and EpiPen.com/EpiPenSupply to review the lots of product impacted by the expiration extension.